Clinical Trials Logo

Uveitis, Posterior clinical trials

View clinical trials related to Uveitis, Posterior.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05523765 Active, not recruiting - Clinical trials for Non-infectious Intermediate Uveitis

A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis

NEPTUNE
Start date: November 14, 2022
Phase: Phase 2
Study type: Interventional

This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with active intermediate, posterior, or pan non-infectious uveitis (NIU).

NCT ID: NCT01717170 Active, not recruiting - Posterior Uveitis Clinical Trials

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

STOP-Uveitis
Start date: March 2013
Phase: Phase 1/Phase 2
Study type: Interventional

In the STOP-UVEITIS study, we propose to evaluate the safety, tolerability, and bioactivity of two doses of Tocilizumab (4mg/kg and 8mg/kg), administered monthly, in patients with non-infectious intermediate, posterior, or panuveitis.